Scholl Hendrik Peter
Belite Bio, Inc · Chief Medical Officer
Scholl Hendrik Peter is listed in filings as Chief Medical Officer at Belite Bio, Inc. This profile follows SEC Form 4 activity through Jun 22, 2026, including sale activity. Recent filings connect the profile to Belite Bio, Inc (BLTE). The current snapshot covers public activity from Apr 23, 2026 to Jun 22, 2026. Reported amounts are shown as $14.1K to $707.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $150k1k shares | SellJun 16, 2026 | $145.02 | $161.08 | |
| $272k1.9k shares | SellJun 16, 2026 | $143.55 | $161.08 | |
| $64k450 shares | SellJun 16, 2026 | $142.20 | $161.08 | |
| $14k100 shares | SellJun 16, 2026 | $141.83 | $161.08 | |
| $76k540 shares | SellJun 16, 2026 | $140.58 | $161.08 | |
| $438k3.1k shares | SellJun 16, 2026 | $139.57 | $161.08 | |
| $108k784 shares | SellJun 16, 2026 | $138.18 | $161.08 | |
| $283k2.1k shares | SellJun 16, 2026 | $137.61 | $161.08 |